Sanofi completed the acquisition of Qunol.

Sanofi, an innovative global healthcare company, completed the acquisition of Qunol, a US-based brand in health & wellness. Financial terms were not disclosed. “The acquisition of Qunol further strengthens our portfolio in the wellness category. It taps into the growing ‘healthy aging’ segment and fills one of our white spaces in the US, unlocking an opportunity for us to build on our US presence and accelerate our growth. VMS now functions as long-term support for overall health and wellness where proactive preventive health has become the new norm post-pandemic. We are excited to welcome Qunol and, with this addition to our consumer healthcare portfolio, reinforce our commitment to bring more health into the hands of people,” Julie Van Ongevalle, Sanofi Executive Vice President.